Literature DB >> 9243613

Age-related loss of calbindin from human basal forebrain cholinergic neurons.

C K Wu1, M M Mesulam, C Geula.   

Abstract

Loss of basal forebrain cholinergic neurons (BFCN) occurs in many age-related neurological diseases. Although age is the common risk factor in these disorders, no consistent age-related changes have been reported in the human BFCN. We investigated age-related alterations in choline acetyltransferase (ChAT), low-affinity nerve growth factor receptor (p75LNGFR) and calbindin-D28k (CalBP) immunoreactivity in the human BFCN. No significant age-related changes were observed in ChAT or p75LNGFR immunoreactivity. By contrast, normal aging was accompanied by a selective, substantial and significant loss of CalBP immunoreactivity from the BFCN. Other CalBP-positive neurons were unchanged. Loss of the calcium buffering capacity conferred by CalBP may leave the BFCN vulnerable to damage in neurodegenerative disorders.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9243613     DOI: 10.1097/00001756-199707070-00024

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  10 in total

Review 1.  Advances in the pharmacotherapy of Alzheimer's disease.

Authors:  Serge Gauthier
Journal:  CMAJ       Date:  2002-03-05       Impact factor: 8.262

2.  Calbindin-D28K, parvalbumin, and calretinin in young and aged human locus coeruleus.

Authors:  Sydney Lamerand; Ryan Shahidehpour; Ivan Ayala; Tamar Gefen; M-Marsel Mesulam; Eileen Bigio; Changiz Geula
Journal:  Neurobiol Aging       Date:  2020-06-15       Impact factor: 4.673

3.  In vivo AAV-mediated expression of calbindin-D₂₈k in rat basal forebrain cholinergic neurons.

Authors:  Nicholas Nagykery; Ernest F Terwilliger; Changiz Geula
Journal:  J Neurosci Methods       Date:  2012-09-27       Impact factor: 2.390

4.  Age-related loss of calcium buffering and selective neuronal vulnerability in Alzheimer's disease.

Authors:  David Riascos; Dianne de Leon; Alaina Baker-Nigh; Alexander Nicholas; Rustam Yukhananov; Jing Bu; Chuang-Kuo Wu; Changiz Geula
Journal:  Acta Neuropathol       Date:  2011-08-27       Impact factor: 17.088

5.  Alterations of Ca²⁺-responsive proteins within cholinergic neurons in aging and Alzheimer's disease.

Authors:  David Riascos; Alexander Nicholas; Ravand Samaeekia; Rustam Yukhananov; M-Marsel Mesulam; Eileen H Bigio; Sandra Weintraub; Ling Guo; Changiz Geula
Journal:  Neurobiol Aging       Date:  2013-12-25       Impact factor: 4.673

6.  Loss of calbindin-D28K is associated with the full range of tangle pathology within basal forebrain cholinergic neurons in Alzheimer's disease.

Authors:  Saman S Ahmadian; Aras Rezvanian; Melanie Peterson; Sandra Weintraub; Eileen H Bigio; Marek-Marsel Mesulam; Changiz Geula
Journal:  Neurobiol Aging       Date:  2015-09-06       Impact factor: 4.673

7.  Cholinergic neuronal and axonal abnormalities are present early in aging and in Alzheimer disease.

Authors:  Changiz Geula; Nicholas Nagykery; Alexander Nicholas; Chuang-Kuo Wu
Journal:  J Neuropathol Exp Neurol       Date:  2008-04       Impact factor: 3.685

8.  Calcium-sensitive regulation of monoamine oxidase-A contributes to the production of peroxyradicals in hippocampal cultures: implications for Alzheimer disease-related pathology.

Authors:  Xia Cao; Zelan Wei; Geraldine G Gabriel; XinMin Li; Darrell D Mousseau
Journal:  BMC Neurosci       Date:  2007-09-16       Impact factor: 3.288

Review 9.  Calcium-Binding Proteins as Determinants of Central Nervous System Neuronal Vulnerability to Disease.

Authors:  Richard Fairless; Sarah K Williams; Ricarda Diem
Journal:  Int J Mol Sci       Date:  2019-04-30       Impact factor: 5.923

Review 10.  Basal forebrain cholinergic system in the dementias: Vulnerability, resilience, and resistance.

Authors:  Changiz Geula; Sara R Dunlop; Ivan Ayala; Allegra S Kawles; Margaret E Flanagan; Tamar Gefen; Marek-Marsel Mesulam
Journal:  J Neurochem       Date:  2021-08-06       Impact factor: 5.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.